| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 6,843,145 | 6,392,103 | 6,390,523 | 6,033,240 | | Cost of Revenue | 4,608,879 | 4,358,295 | 4,217,436 | 3,905,095 | | | Gross Profit | 2,234,266 | 2,033,808 | 2,173,087 | 2,128,145 | | | Operating Expenses | | Research Development | 197,374 | 191,031 | 196,520 | 190,194 | | Selling General and Administrative | 172,001 | 161,300 | 164,632 | 159,164 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,864,891 | 1,681,477 | 1,811,935 | 1,778,787 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,864,891 | 1,681,477 | 1,811,935 | 1,778,787 | | Interest Expense | 61,354 | 66,041 | 71,519 | 68,622 | | Income Before Tax | 1,803,537 | 1,615,436 | 1,740,416 | 1,710,165 | | Income Tax Expense | 377,731 | 308,587 | 357,203 | 356,168 | | Minority Interest | (5,811) | (6,395) |
-
|
-
| | | | Net Income From Continuing Ops | 1,419,995 | 1,300,454 | 1,383,213 | 1,353,997 | | | Non-recurring Events | | Discontinued Operations |
-
| 37,850 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,419,995 | 1,338,304 | 1,383,213 | 1,353,997 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,419,995 | $1,338,304 | $1,383,213 | $1,353,997 |
|
1.47% Nasdaq 
Income Statement
